United Therapeutics | Bienes



Assets Cambio Fecha
Amarin USD 750.62M 49.24M 2024-09
Ardelyx USD 435.75M 67.89M 2024-12
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
J&J USD 193.67B 13.57B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Pfizer USD 213.4B 6.08B 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



United Therapeutics Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.